{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:02:21Z","timestamp":1758045741900,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00658-2","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:13:10Z","timestamp":1757657590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of clinicopathologic features of a genetic myelodysplastic syndrome classification in an independent cohort"],"prefix":"10.1007","volume":"18","author":[{"given":"Pranav Pramod","family":"Patwardhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raniah D.","family":"Al Amri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Baloda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Aarabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Djokic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika M.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathanael G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,12]]},"reference":[{"issue":"14","key":"658_CR1","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1056\/NEJMra1904794","volume":"383","author":"M Cazzola","year":"2020","unstructured":"Cazzola M (2020) Myelodysplastic syndromes. N Engl J Med 383(14):1358\u20131374. https:\/\/doi.org\/10.1056\/NEJMra1904794","journal-title":"N Engl J Med"},{"issue":"10","key":"658_CR2","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3324\/haematol.2019.222059","volume":"104","author":"P Valent","year":"2019","unstructured":"Valent P, Orazi A, Savona MR et al (2019) Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions. Haematologica 104(10):1935\u20131949. https:\/\/doi.org\/10.3324\/haematol.2019.222059","journal-title":"Haematologica"},{"issue":"2","key":"658_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V et al (2014) Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28(2):241\u2013247. https:\/\/doi.org\/10.1038\/leu.2013.336","journal-title":"Leukemia"},{"issue":"7","key":"658_CR4","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719. https:\/\/doi.org\/10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"issue":"11","key":"658_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP et al (2022) International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200\u20131228. https:\/\/doi.org\/10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"658_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27656","author":"DA Arber","year":"2025","unstructured":"Arber DA, Orazi A (2025) Classification of myelodysplastic, myeloproliferative, and myelodysplastic\/myeloproliferative neoplasms: the past, present, and future. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.27656","journal-title":"Am J Hematol"},{"issue":"7","key":"658_CR7","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD (2002) The world health organization (WHO) classification of the myeloid neoplasms. Blood 100(7):2292\u20132302. https:\/\/doi.org\/10.1182\/blood-2002-04-1199","journal-title":"Blood"},{"issue":"5","key":"658_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5):937\u2013951. https:\/\/doi.org\/10.1182\/blood-2009-03-209262","journal-title":"Blood"},{"issue":"6","key":"658_CR9","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079\u20132088","journal-title":"Blood"},{"issue":"12","key":"658_CR10","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J et al (2012) Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120(12):2454\u20132465. https:\/\/doi.org\/10.1182\/blood-2012-03-420489","journal-title":"Blood"},{"issue":"7","key":"658_CR11","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200008","volume":"1","author":"E Bernard","year":"2022","unstructured":"Bernard E, Tuechler H, Greenberg PL et al (2022) Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid 1(7):EVIDoa2200008. https:\/\/doi.org\/10.1056\/EVIDoa2200008","journal-title":"NEJM Evid"},{"issue":"4","key":"658_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41375-023-01855-7","volume":"37","author":"S Huber","year":"2023","unstructured":"Huber S, Haferlach T, Muller H et al (2023) Mds subclassification-do we still have to count blasts? Leukemia 37(4):942\u2013945. https:\/\/doi.org\/10.1038\/s41375-023-01855-7","journal-title":"Leukemia"},{"issue":"11","key":"658_CR13","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1200\/JCO.20.01659","volume":"39","author":"M Bersanelli","year":"2021","unstructured":"Bersanelli M, Travaglino E, Meggendorfer M et al (2021) Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes. J Clin Oncol 39(11):1223\u20131233. https:\/\/doi.org\/10.1200\/JCO.20.01659","journal-title":"J Clin Oncol"},{"issue":"1","key":"658_CR14","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1038\/s41467-023-38515-4","volume":"14","author":"T Kewan","year":"2023","unstructured":"Kewan T, Durmaz A, Bahaj W et al (2023) Molecular patterns identify distinct subclasses of myeloid neoplasia. Nat Commun 14(1):3136. https:\/\/doi.org\/10.1038\/s41467-023-38515-4","journal-title":"Nat Commun"},{"issue":"15","key":"658_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1182\/blood.2023023727","volume":"144","author":"E Bernard","year":"2024","unstructured":"Bernard E, Hasserjian RP, Greenberg PL et al (2024) Molecular taxonomy of myelodysplastic syndromes and its clinical implications. Blood 144(15):1617\u20131632. https:\/\/doi.org\/10.1182\/blood.2023023727","journal-title":"Blood"},{"key":"658_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100823","author":"V Baloda","year":"2025","unstructured":"Baloda V, Al Amri R, Patwardhan PP et al (2025) Myeloid neoplasms with oligomonocytosis exhibit heterogenous pathologic and genetic features. Mod Pathol. https:\/\/doi.org\/10.1016\/j.modpat.2025.100823","journal-title":"Mod Pathol"},{"issue":"12","key":"658_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1182\/blood.2023021199","volume":"143","author":"F Baumgartner","year":"2024","unstructured":"Baumgartner F, Baer C, Bamopoulos S et al (2024) Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022. Blood 143(12):1139\u20131156. https:\/\/doi.org\/10.1182\/blood.2023021199","journal-title":"Blood"},{"issue":"9","key":"658_CR18","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1038\/s41375-024-02348-x","volume":"38","author":"R Al Amri","year":"2024","unstructured":"Al Amri R, Baloda V, Monaghan SA et al (2024) Validation of independent prognostic significance of blast count in a large cohort of MDS patients. Leukemia 38(9):2064\u20132067. https:\/\/doi.org\/10.1038\/s41375-024-02348-x","journal-title":"Leukemia"},{"issue":"1","key":"658_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41375-024-02484-4","volume":"39","author":"S Huber","year":"2025","unstructured":"Huber S, Haferlach T, Hutter S, Hoermann G, Kern W, Haferlach C (2025) Relevance of blast counts for genetic subclassification in MDS. Leukemia 39(1):271\u2013273. https:\/\/doi.org\/10.1038\/s41375-024-02484-4","journal-title":"Leukemia"},{"issue":"10","key":"658_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41591-020-1008-z","volume":"26","author":"E Bernard","year":"2020","unstructured":"Bernard E, Nannya Y, Hasserjian RP et al (2020) Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. Nat Med 26(10):1549\u20131556. https:\/\/doi.org\/10.1038\/s41591-020-1008-z","journal-title":"Nat Med"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00658-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:02:57Z","timestamp":1757703777000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-025-00658-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00658-2","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"type":"print","value":"1868-9256"},{"type":"electronic","value":"1865-5785"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Pittsburgh IRB under protocol STUDY20070099.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"A waiver of consent was approved due to the retrospective nature of the study and minimal risk to patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"NGB is Editor-in-Chief of the Journal of Hematopathology.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study consent for publication is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"42"}}